Tvm V Life Science Ventures Gmbh & Co Kg - Net Worth and Insider Trading
Tvm V Life Science Ventures Gmbh & Co Kg Net Worth
The estimated net worth of Tvm V Life Science Ventures Gmbh & Co Kg is at least $13 Million dollars as of 2024-09-20. Tvm V Life Science Ventures Gmbh & Co Kg is the 10% Owner of Enanta Pharmaceuticals Inc and owns about 1,178,534 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $13 Million. Details can be seen in Tvm V Life Science Ventures Gmbh & Co Kg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tvm V Life Science Ventures Gmbh & Co Kg has not made any transactions after 2014-03-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Tvm V Life Science Ventures Gmbh & Co Kg
Tvm V Life Science Ventures Gmbh & Co Kg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tvm V Life Science Ventures Gmbh & Co Kg owns 3 companies in total, including Enanta Pharmaceuticals Inc (ENTA) , Argos Therapeutics Inc (ARGSQ) , and bluebird bio Inc (BLUE) .
Insider Ownership Summary of Tvm V Life Science Ventures Gmbh & Co Kg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2014-03-04 | 10 percent owner |
| ARGSQ | Argos Therapeutics Inc | 2014-02-06 | 10 percent owner |
| BLUE | bluebird bio Inc | 2013-06-18 | 10 percent owner |
Tvm V Life Science Ventures Gmbh & Co Kg Latest Holdings Summary
Tvm V Life Science Ventures Gmbh & Co Kg currently owns a total of 1 stock. Tvm V Life Science Ventures Gmbh & Co Kg owns 1,178,534 shares of Enanta Pharmaceuticals Inc (ENTA) as of March 4, 2014, with a value of $13 Million.
Latest Holdings of Tvm V Life Science Ventures Gmbh & Co Kg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2014-03-04 | 1,178,534 | 11.05 | 13,016,908 |
Holding Weightings of Tvm V Life Science Ventures Gmbh & Co Kg
Tvm V Life Science Ventures Gmbh & Co Kg Form 4 Trading Tracker
According to the SEC Form 4 filings, Tvm V Life Science Ventures Gmbh & Co Kg has made a total of 0 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 439,334 shares on March 4, 2014, which brought Tvm V Life Science Ventures Gmbh & Co Kg around $17 Million.
Insider Trading History of Tvm V Life Science Ventures Gmbh & Co Kg
- 1
Tvm V Life Science Ventures Gmbh & Co Kg Trading Performance
GuruFocus tracks the stock performance after each of Tvm V Life Science Ventures Gmbh & Co Kg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tvm V Life Science Ventures Gmbh & Co Kg is 6.5%. GuruFocus also compares Tvm V Life Science Ventures Gmbh & Co Kg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tvm V Life Science Ventures Gmbh & Co Kg within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Tvm V Life Science Ventures Gmbh & Co Kg's insider trading performs compared to the benchmark.
Performance of Tvm V Life Science Ventures Gmbh & Co Kg
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.66 | | | | | |
| Relative Return to S&P 500(%) | 19.48 | | | | | |
Tvm V Life Science Ventures Gmbh & Co Kg Ownership Network
Tvm V Life Science Ventures Gmbh & Co Kg Owned Company Details
What does Enanta Pharmaceuticals Inc do?
Who are the key executives at Enanta Pharmaceuticals Inc?
Tvm V Life Science Ventures Gmbh & Co Kg is the 10 percent owner of Enanta Pharmaceuticals Inc. Other key executives at Enanta Pharmaceuticals Inc include Chief Medical Officer Scott T. Rottinghaus , Sr. VP & New Product Dev. Tara Lynn Kieffer , and Sr. VP & Business Dev. Brendan Luu .
Enanta Pharmaceuticals Inc (ENTA) Insider Trades Summary
Over the past 18 months, Tvm V Life Science Ventures Gmbh & Co Kg made no insider transaction in Enanta Pharmaceuticals Inc (ENTA). Other recent insider transactions involving Enanta Pharmaceuticals Inc (ENTA) include a net sale of 12,479 shares made by Scott T. Rottinghaus , a net sale of 9,391 shares made by Tara Lynn Kieffer , and a net sale of 15,295 shares made by Terry Vance .
In summary, during the past 3 months, insiders sold 11,945 shares of Enanta Pharmaceuticals Inc (ENTA) in total and bought 0 shares, with a net sale of 11,945 shares. During the past 18 months, 53,756 shares of Enanta Pharmaceuticals Inc (ENTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 53,756 shares.
Enanta Pharmaceuticals Inc (ENTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enanta Pharmaceuticals Inc Insider Transactions
Tvm V Life Science Ventures Gmbh & Co Kg Mailing Address
Above is the net worth, insider trading, and ownership report for Tvm V Life Science Ventures Gmbh & Co Kg. You might contact Tvm V Life Science Ventures Gmbh & Co Kg via mailing address: C/o Tvm Capital Corp, 101 Arch Street Suite 1950, Boston Ma 02110.
Discussions on Tvm V Life Science Ventures Gmbh & Co Kg
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
